Cryptosporidium ELISA

$458.00
Catalog
86-CPSHU-E01

The Cryptosporidium ELISA is an enzyme-linked immunosorbent assay for the qualitative determination of of Cryptosporidium parvum and Cryptosporidium hominis in human stool samples. The Cryptosporidium ELISA for simultaneous determination of both pathogens in stool samples is an important alternative to the diagnosis by microscopic examination. Its sensitivity equals that of a microscopic examination, requires no personnel specifically trained in parasitology, is simple and can be conducted quickly, and it is not dependent on finding in-tact organisms (cysts or trophozoites) in the stool sample. For Research Use Only. Not for use in diagnostic procedures.

Cryptosporidiosis is a protozoan infection caused by the Cryptosporidium genus. This parasite is found widespread in animals, and it has significant presence as a pathogenic microorganism in domestic animals, calves in particular. In immune competent patients the disease manifests as a self-healing gastroenteritis. The diarrhea lasts between 3 and 10 days and may be accompanied by fever and gastrointestinal symptoms such as nausea and pain similar to that of giardiasis (lambliasis). The symptoms and effects are substantially more severe in immune compromised patients, where the course of diarrhea is very severe and persistent. The infection may pass from an animal to the human through contaminated water, but it is also contagious on personal contact with a patient.
Species
Human
Regulatory Status
Research Use Only. Not for Use in Diagnostic Procedures.
Product Distribution
Available in USA Only
Range
Cut-off Assay
Sensitivity
1.56 x 10^4 cysts / reaction
Sizes
96 Wells
Sample Types
Stool
Inc Time Hour
1
Inc Time Overnight
No
Inc Time See Protocol
No
Sample Size
100 uL
Sample Size 2
50 mg
Detection
Colorimetric

Cryptosporidium ELISA

86-CPSHU-E01

Billing Address

Shipping Address

Resources to advance your discoveries 

Recent posts

8 Questions to Ask Before Choosing an Allergy Testing Platform
8 Questions to Ask Before Choosing an Allergy Testing Platform
1. What percentage of your IgE allergy testing panel consists of molecular allergens rather than allergen extracts? The ALEX2 IgE allergen panel consists of 117 extracts and 183 molecular allergens. This represents the largest panel of molecular allergens on the market, including 50 unique...
View Now
Understanding IgE Allergy Test Results
Understanding IgE Allergy Test Results
Cases of food and environmental allergies have been increasing over the last decade. While conservative estimates suggest IgE-mediated allergy affects 6-8% of children and 2-3% of adults, some estimates are as high as 30%.3, 2 Symptoms can range from mild to severe and include itching, hives,...
View Now
Improving Food Elimination Diets with IgG Testing
Improving Food Elimination Diets with IgG Testing
Food sensitivity or food intolerance involves a non-allergic response to a food or food additive. In a recent on-line survey conducted in the U.S., 24% of adults aged 18 to 79 reported a food intolerance. While a food allergy is typically mediated by IgE antibodies, adverse reactions to food...
View Now

Recent posts

An End to Subjective RPR Reading?
An End to Subjective RPR Reading? Development of a Novel Automated Nontreponemal Immunoassay for Syphilis
Discover ALPCO’s novel automated nontreponemal immunoassay for syphilis testing. Reduce subjectivity, improve workflow efficiency, and support faster treatment decisions.
View Now
Variation In Calprotectin Results by Methodology
Same Sample, Different Result? What New Research Reveals About Fecal Calprotectin Variability
In a head-to-head comparison of FDA-cleared assays and a novel ALPCO method, investigators observed wide variability in specificity and false-positive rates across platforms, raising important questions about standardization and clinical interpretation.
View Now
ALPCO News
NuvinkaDx Announces Major Milestones for Portfolio Companies GeneProof and ALPCO
July 22, 2025 – Salem, NH – NuvinkaDx, a leading innovator in diagnostic solutions, today announced two significant product and regulatory milestones from its operating companies, GeneProof and ALPCO.
View Now

Biomarkers of Energy Homeostasis Brochure

Energy homeostasis is a focus of research into diabetes and obesity. Read about how our assays in this area can assist both academic and industry researchers.

Complement System Solutions for Drug Development and Clinical Research Datasheet

The complement system is essential to innate immunity from a variety of diseases. ALPCO’s full range of complement system immunoassays can drive discovery.

Melatonin Products for Sleep Disorder-Related Research Datasheet

The melatonin hormone affects the circadian rhythm and sleep-wake cycle. Find out about our immunoassays and products that explore melatonin and sleep disorders.